Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-25-003538
Filing Date
2025-03-24
Accepted
2025-03-24 16:28:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20250324xdefa14a.htm DEFA14A 17240
2 GRAPHIC tmb-20250324xdefa14a_bg001.jpg GRAPHIC 136967
3 GRAPHIC tmb-20250324xdefa14a_bg002.jpg GRAPHIC 86339
  Complete submission text file 0001558370-25-003538.txt   319256
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35565 | Film No.: 25764503
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)